CellWell record HH-465375
New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering.
Daniel Gaudet; M. Larouche; F. Raal; A. Catapano
Circulation Research ยท 2026
In plain language
This review describes how apoB-containing particles drive cardiovascular risk and surveys emerging therapies, proposing that shifting from an LDL cholesterol focus to an apoB focus may better reduce atherosclerosis and pancreatitis risk.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-465375
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.